AP245
Medisinstart
Hva er Medisinstart? I kurset får du en innføring i apotektjenesten Medisinstart. Du får eksempler på vanlige utfordringer ved legemiddelbruk. Videre vil du få tips til hvordan du kan tilpasse samtalen til pasienter med ulike etterlevelsesutfordringer.
Om kurset
Etter endt kurs er målet at du
- har kunnskap om vanlige utfordringer ved oppstart med et nytt legemiddel
- har kunnskap om viktige årsaker til manglende etterlevelse
- har kunnskap om nytteverdien Medisinstart kan ha for pasienter
- forstår hvordan Medisinstart skal gjennomføres i praksis
- forstår hvordan du skal bruke samtaleguidene og faktaark
Kurset bør tas før kurset «AP206 Den gode Medisinstartsamtalen».
-
Kilder: Medisinstart og New Medicine Service
- Barber N, Parsons J, Clifford S, et al. Patients’ problems with new medication for chronic conditions. Qual Saf Health Care. 2004;13(3):172-5
- Bremer S, Henjum S, Sæther EM, et al. Drug-related problems and satisfaction among patients receiving pharmacist-led consultations at the initiation of cardiovascular drugs. Res Social Adm Pharm. 2022;18(11):3939-47
- Elliott RA, Boyd MJ, Salema NE, et al. Supporting adherence for people starting a new medication for a long-term condition through community pharmacies: a pragmatic randomised controlled trial of the New Medicine Service. BMJ Qual Saf. 2016;25(10):747-58
- Hovland R, Bremer S, Frigaard C, et al. Effect of a pharmacist-led intervention on adherence among patients with a first-time prescription for a cardiovascular medicine: a randomized controlled trial in Norwegian pharmacies. Int J Pharm Pract. 2020;28(4):337-45
- Latif A, Waring J, Watmough D, et al. ‘I expected just to walk in, get my tablets and then walk out’: on framing new community pharmacy services in the English healthcare system. Sociol Health Illn. 2018;40(6):1019-36
- Merks P, Chełstowska B, Religioni U, et al. Enhancing Patient Adherence to Newly-Prescribed Medicine for Chronic Diseases: A Comprehensive Review and Cost-Effective Approach to Implementing the New Medicine Service in Community Pharmacies in Poland. Med Sci Monit. 2024;30
Kilder: Etterlevelse
- Ho, P., Bryson, C., & Rumsfeld, J. (2009). Medication adherence: Its importance in Cardiovascular Outcomes. Circulation, 119(23), 3031
- Osterberg L, Blaschke T. Adherence to Medication. New England Journal of Medicine. 2005;353(5):487-97
- Vermeire E, Hearnshaw H, Van Royen P, et al. Patient adherence to treatment: three decades of research. A comprehensive review. J Clin Pharm Ther. 2001;26(5):331-42
- Vrijens, B.; De Geest, S.; Hughes, D.A.; Przemyslaw, K.; Demonceau, J.; Ruppar, T.; Dobbels, F.; Fargher, E.; Morrison, V.; Lewek, P.; et al. A new taxonomy for describing and defining adherence to medications. Br. J. Clin. Pharmacol. 2012, 73, 691–705
- World Health Organization. Adherence to Long-Term Therapies: Evidence for Action. Geneva: WHO, 2003
Kilder: Kommunikasjon og gjennomføringsform
- Hammersley V, Donaghy E, Parker R, et al. Comparing the content and quality of video, telephone, and face-to-face consultations: a non-randomised, quasi-experimental, exploratory study in UK primary care. Br J Gen Pract. 2019;69(686):e595-e604.
- Helsedirektoratet (2017). Motiverende intervju som metode [nettdokument]. Oslo: Helsedirektoratet (siste faglige endring 07. mars 2017, lest 08. desember 2024). Tilgjengelig fra: https://www.helsedirektoratet.no/tema/motiverende-intervju-mi/motiverende-intervju-som-metode
- Hewitt H, Gafaranga J, McKinstry B. Comparison of face-to-face and telephone consultations in primary care: qualitative analysis. Br J Gen Pract. 2010;60(574):e201-12
- Miller, W. R., & Rollnick, S. (2012). Motivational interviewing: Helping people change. Guilford press.